As the U.S. stock market navigates a mixed landscape of earnings reports and inflation data, major indexes like the S&P 500 and Nasdaq Composite are on track for gains, reflecting investor optimism ...

HeartBeam (NASDAQ: BEAT) , a medical technology company advancing cardiac care, has submitted a 510 (k) application to the U.S. Food and Drug Administration (“FDA”) for its 12-lead electrocardiogram ( ...

SANTA CLARA, Calif. - HeartBeam, Inc. (NASDAQ: BEAT), a $56.5 million market cap pioneer in medical technology currently trading at $2.12 per share, has announced the submission of a 510(k) ...

Deepgram, the leading voice AI platform for developers building speech-to-text (STT), text-to-speech (TTS), and full speech-to-speech (STS) offerings, today announced record business growth and ...

REPAY , a leading provider of vertically-integrated payment solutions, today announced a strategic integration with Worth, the all-in-one fintech platform for underwriting and onboarding workflow ...

The FDA submission is backed by robust data from the VALID-ECG pivotal study, which enrolled 198 patients across five ...

HeartBeam Inc is a medical technology company primarily focusing on developing and commercializing higher resolution ambulatory Electrocardiogram ("ECG") solutions that enable the detection and ...

Enhance your stock picks with dividend metrics like per-share dividends, yield, frequency, payout ratios, and more.